Krawczyk , P. (2013) “Role of molecular examinations in qualification to first line treatment with erlotinib in NSCLC patients based on EUTARCstudy results”, OncoReview, 3(1(9), pp. 26-33. Available at: https://journalsmededu.pl/index.php/OncoReview/article/view/332 (Accessed: 4July2024).